Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.49 |
| ▸ | LPL | P06858 | 6/20 | 0.49 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.32 |
| ▸ | KIF11 | P52732 | 2/20 | 0.32 |
| ▸ | GCGR | P47871 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29778719 | 1.00 | LIPG (0.49) | LIPGLPLMAPKAPK2KIF11GCGR | |
| SCHEMBL21148893 | 0.90 | LIPG (0.37) | LIPGLPLKIF11TGFBR1HIF1A | |
| SCHEMBL25397528 | 0.89 | MAP4K4 (0.39) | LIPGLPLMAPKAPK2KIF11GCGR | |
| SCHEMBL22889684 | 0.89 | LIPG (0.46) | LIPGLPLKIF11HIF1ANR1I2 | |
| SCHEMBL24277796 | 0.86 | LIPG (0.34) | LIPGLPLKIF11HIF1A | |
| SCHEMBL24277712 | 0.86 | LIPG (0.41) | LIPGLPLKIF11HIF1A | |
| SCHEMBL29778746 | 0.84 | LIPG (0.51) | LIPGLPLMAPKAPK2TGFBR1 | |
| SCHEMBL24625922 | 0.84 | LIPG (0.51) | LIPGLPLMAPKAPK2TGFBR1 | |
| SCHEMBL24282121 | 0.83 | HIF1A (0.38) | LIPGLPLHIF1A | |
| SCHEMBL21148642 | 0.82 | LIPG (0.47) | LIPGLPLKIF11TGFBR1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114763365-A | Organometallic compound, organic light emitting device including the same, and electronic apparatus including the organic light emitting device | 三星电子株式会社 | 2022-07-19 | — | — | CN | disclosed |
| US-20220220142-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220142-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | PYM1, SOD1, SLC39A11 | LIPG 4496/4885LPL 3357/4885MAPKAPK2 4169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.